Similar articles for PMID: 7468843

Year	Number of Results
1963	1
1971	1
1973	1
1978	1
1981	2
1982	2
1983	1
1985	1
1986	2
1987	1
1992	1
1993	1
1994	1
1998	1
1999	3
2000	3
2002	3
2003	2
2004	2
2005	3
2006	2
2007	3
2008	2
2009	4
2010	4
2011	4
2012	11
2013	7
2014	5
2015	3
2017	1
2018	1
2021	1
2023	1
2024	0

1

Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity.

Geller B, Guttmacher LB, Bleeg M. Geller B, et al. Am J Psychiatry. 1981 Mar;138(3):388-9. doi: 10.1176/ajp.138.3.388. Am J Psychiatry. 1981. PMID: 7468843 No abstract available.

2

Commentary: considerations on the pharmacotherapy of attention deficits and hyperactivity in children with autism and other pervasive developmental disorders.

Nicolson R, Castellanos FX. Nicolson R, et al. J Autism Dev Disord. 2000 Oct;30(5):461-2. doi: 10.1023/a:1005511809545. J Autism Dev Disord. 2000. PMID: 11098884 No abstract available.

3

Treatment of hyperactivity in children with pervasive developmental disorders.

Scahill L, Pachler M. Scahill L, et al. J Child Adolesc Psychiatr Nurs. 2007 Feb;20(1):59-62. doi: 10.1111/j.1744-6171.2007.00080.x. J Child Adolesc Psychiatr Nurs. 2007. PMID: 17284238 Review. No abstract available.

4

[Eating disorder associated with developmental dysfunction].

Wada Y. Wada Y. Seishin Shinkeigaku Zasshi. 2010;112(8):750-7. Seishin Shinkeigaku Zasshi. 2010. PMID: 21077394 Japanese. No abstract available.

5

A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.

van der Meer JM, Harfterkamp M, van de Loo-Neus G, Althaus M, de Ruiter SW, Donders AR, de Sonneville LM, Buitelaar JK, Hoekstra PJ, Rommelse NN. van der Meer JM, et al. J Clin Psychopharmacol. 2013 Dec;33(6):824-7. doi: 10.1097/JCP.0b013e31829c764f. J Clin Psychopharmacol. 2013. PMID: 24018545 Clinical Trial. No abstract available.

6

Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.

Weller EB, Rowan A, Elia J, Weller RA. Weller EB, et al. J Clin Psychiatry. 1999;60 Suppl 15:5-11. J Clin Psychiatry. 1999. PMID: 10418807 Review.

7

Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.

Lee DO, Ousley OY. Lee DO, et al. J Child Adolesc Psychopharmacol. 2006 Dec;16(6):737-46. doi: 10.1089/cap.2006.16.737. J Child Adolesc Psychopharmacol. 2006. PMID: 17201617

8

Attention-deficit/hyperactivity disorder.

Lambe JA. Lambe JA. N Z Med J. 2003 Apr 4;116(1171):U391. N Z Med J. 2003. PMID: 12740638 No abstract available.

9

[Attention-deficit / hyperactivity disorder in autism spectrum disorders].

Montiel-Nava C, Peña JA. Montiel-Nava C, et al. Invest Clin. 2011 Jun;52(2):195-204. Invest Clin. 2011. PMID: 21866791 Review. Spanish.

10

Autism spectrum disorders, attention deficit/hyperactivity disorder, and sleep disorders.

Ming X, Walters AS. Ming X, et al. Curr Opin Pulm Med. 2009 Nov;15(6):578-84. doi: 10.1097/MCP.0b013e3283319a9a. Curr Opin Pulm Med. 2009. PMID: 19713848 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year